Dr. Jotte on the Low Rate of Screening in Lung Cancer

Video

Robert M. Jotte, MD, PhD, medical director and co-chair of the USON Thoracic Committee at Rocky Mountain Cancer Centers, discusses the low rate of screening for lung cancer.

Robert M. Jotte, MD, PhD, medical director and co-chair of the USON Thoracic Committee at Rocky Mountain Cancer Centers, discusses the low rate of screening for lung cancer.

There are many reasons why there is such a low rate of lung cancer screening, explains Jotte. The primary reason is that the topic is not being brought up. Primary care providers are expected to address a variety of problems in a relatively short office visit, and so lung cancer screening is often overlooked. Physicians must decipher what the immediate risk to the patient is, and proceed accordingly.

In a 15-minute appointment, a patient is expected to disclose all their problems, have the physician address those problems, and take a couple minutes to discuss a risk that may never materialize. However, for the patients in whom it does materialize, it can be lifesaving, says Jotte.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,